戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 omyelitis can develop despite treatment with intravenous immune globulin.
2 equate responses to conventional therapy and intravenous immune globulin.
3 rticosteroids, immunosuppressive agents, and intravenous immune globulin.
4 mmune-mediated, we evaluated the efficacy of intravenous immune globulin.
5 robably safer, and easier to administer than intravenous immune globulin.
6 Forty-five of the 72 children were receiving intravenous immune globulin.
7 rapy protocol consisting of rituximab and/or intravenous immune globulin.
8 received plasmapheresis every other day with intravenous immune globulin 100 mg/kg starting 1 week be
9 dy-surface area) once weekly for 3 weeks and intravenous immune globulin (2 g per kilogram of body we
10  with peripartum cardiomyopathy treated with intravenous immune globulin (2 g/kg) with those of 11 re
11 ents then received conventional therapy with intravenous immune globulin, 2 g per kilogram, as well a
12 baclofen, 3 of 3 treated) and immunotherapy (intravenous immune globulin, 3 of 4 treated and plasmaph
13     Treatment of acute Kawasaki disease with intravenous immune globulin and aspirin reduces the risk
14 d at 2000/mm3 despite empiric treatment with intravenous immune globulin and methylprednisolone, sple
15     Patients in the U.S. study also received intravenous immune globulin and rituximab after transpla
16 ese findings suggest that the combination of intravenous immune globulin and rituximab may prove effe
17 s) were enrolled and received treatment with intravenous immune globulin and rituximab.
18  of days of fever, rates of retreatment with intravenous immune globulin, and numbers of adverse even
19 to 20% of patients do not respond to initial intravenous immune globulin, and recommendations for add
20 cyclophosphamide pulse therapy together with intravenous immune globulin before transplant and as par
21 lowed by a monthly infusion of rituximab and intravenous immune globulin for 4 consecutive months.
22  receive every other day plasmapheresis with intravenous immune globulin for the initial week.
23                                              Intravenous immune globulin has been reported to improve
24 re treated 1 h later with anti-HCV--negative intravenous immune globulin (IGIV) or hepatitis C immune
25                     Since the institution of intravenous immune globulin in the treatment of the dise
26     Ten patients were treated with high-dose intravenous immune globulin infusions (2 g/kg).
27                                              Intravenous immune globulin is a well-tolerated and effe
28             The combination of rituximab and intravenous immune globulin is effective in patients wit
29                                     Although intravenous immune globulin is the mainstay of initial t
30                         Desensitization with intravenous immune globulin (IVIG) and rituximab improve
31                         Desensitization with intravenous immune globulin (IVIG) and rituximab improve
32                           We now report that intravenous immune globulin (IVIG) derived from pools of
33                                    High-dose intravenous immune globulin (IVIg) has emerged as an imp
34 The immunosuppressive mechanism of action of intravenous immune globulin (IVIG) has remained enigmati
35 lled trial was designed to determine whether intravenous immune globulin (IVIG) improves left ventric
36 tic leukemia (CLL) or multiple myeloma (MM), intravenous immune globulin (IVIg) may be administered t
37                                              Intravenous immune globulin (IVIG) suppresses autoantibo
38                  All 3 patients responded to intravenous immune globulin (IVIG) treatment.
39                  In living-donor recipients, intravenous immune globulin (IVIG) was added to the CMX
40    BACKGROUND.: We have shown that high-dose intravenous immune globulin (IVIG; 2 g/kg x2 doses)+ritu
41 on assay using human immunoglobulin G (IgG) (intravenous immune globulin [IVIG]), AAV-Go.1 had higher
42 ought to evaluate the effect of therapy with intravenous immune globulin on recovery of left ventricu
43 AD65 antibodies, in random order, to receive intravenous immune globulin or placebo for three months,
44 el was 44+/-30% after the second infusion of intravenous immune globulin (P<0.001 for the comparison
45 se 1-2, single-center study examined whether intravenous immune globulin plus rituximab could reduce
46 eatment with corticosteroids, cidofovir, and intravenous immune globulin, PML progressed rapidly, ren
47  variable immunodeficiency who was receiving intravenous immune globulin suddenly had paralysis of al
48                        Over the past decade, intravenous immune globulin therapy (IVIG) has gained wi
49 travenous methylprednisolone to conventional intravenous immune globulin therapy for the routine prim
50 aki disease remains unknown, but fortunately intravenous immune globulin therapy has proved to be eff
51                         The effectiveness of intravenous immune globulin therapy in this disorder sho
52    Therapy for Kawasaki disease resistant to intravenous immune globulin therapy is an area of resear
53 ities and systemic inflammation, but despite intravenous immune globulin therapy, coronary-artery abn
54 apheresis and the administration of low-dose intravenous immune globulin to desensitize 211 HLA-sensi
55       Here, we report a novel approach using intravenous immune globulin to modulate anti-HLA antibod
56                 Penicillin, clindamycin, and intravenous immune globulin (Venoglobulin-S; IVIG) alone
57 f microvascular damage in dermatomyositis by intravenous immune globulin which appears to intercept t
58 nical trials comparing conventional doses of intravenous immune globulin with the most promising dose

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。